Search: onr:"swepub:oai:DiVA.org:uu-524848" >
Model-based effect ...
Model-based effect evaluation of a novel Mmpl3 inhibitor in C3HeB/FeJ compared to BALB/c mouse models and translation to humans
-
- Ayoun Alsoud, Rami (author)
- Uppsala universitet,Institutionen för farmaceutisk biovetenskap,Pharmacokinetics and Quantitative Pharmacology
-
- Keutzer, Lina (author)
- Uppsala universitet,Institutionen för farmaceutisk biovetenskap,Pharmacokinetics and Quantitative Pharmacology
-
- Hölscher, Christoph (author)
- Division of Infection Immunology, Research Centre Borstel, Leibniz Lung Centre, Borstel, Germany,
-
show more...
-
- Redinger, Natalja (author)
- Division of Cellular Microbiology, Research Centre Borstel, Leibniz Lung Centre, Borstel, Germany
-
- Hölscher, Alexandra (author)
- Division of Infection Immunology, Research Centre Borstel, Leibniz Lung Centre, Borstel, Germany
-
- Schaible, Ulrich (author)
- Division of Cellular Microbiology, Research Centre Borstel, Leibniz Lung Centre, Borstel, Germany
-
- Bazaga, Santiago Ferrer (author)
- Universidad Carlos III de Madrid, Madrid, Spain
-
- Fotouhi, Nader (author)
- TB alliance, USA
-
- Serbina, Natalya (author)
- TB alliance, USA
-
- Simonsson, Ulrika S. H., Professor (author)
- Uppsala universitet,Institutionen för farmaceutisk biovetenskap,Institutionen för farmaci
-
show less...
-
(creator_code:org_t)
- English.
- Related links:
-
https://urn.kb.se/re...
Abstract
Subject headings
Close
- Background and Purpose: During tuberculosis drug development, the design of early clinical studies is informed by preclinical animal models. The aim of this work was to describe the exposure-response relationship of a novel inhibitor of mycobacterial MmpL3, prodrug MPL-447, in C3HeB/FeJ mice with non-necrotic or necrotic lesions, and to compare to chronic BALB/c mice information.Experimental Approach: C3HeB/FeJ mice were randomised to placebo and three treatment groups (25, 50 or 100 mg/kg MPL-447). Colony forming unit (CFU) were obtained until week 8 post-treatment. Semi-mechanistic modelling was used to describe growth and killing in relation to exposure. Early bactericidal activity after 14 days (EBA0-14) in humans was predicted using the final model, translational factors and allometric scaling of pharmacokinetics to humans and compared to chronic BALB/c.Key Results: The final model showed 1100% growth and 42% killing of the fast-multiplying bacteria in C3HeB/FeJ mice with necrotic lesions compared to those with non-necrotic lesions. Simulations revealed similar log10CFU reduction on day 14 in C3HeB/FeJ mice with non-necrotic lesions as in chronic BALB/c mice in response to treatment, but 1.7-fold lower reduction in C3HeB/FeJ mice with necrotic lesions. Similar human EBA0-14 was predicted irrespective of the mouse model used. Conclusion and Implications: The difference in killing of fast-multiplying bacteria in C3HeB/FeJ mice with necrotic lesions compared to C3HeB/FeJ mice without or chronic BALB/C mice was not translated to human early clinical predictions, most likely due to low abundance of these bacteria in humans.
Subject headings
- MEDICIN OCH HÄLSOVETENSKAP -- Medicinska och farmaceutiska grundvetenskaper -- Farmaceutiska vetenskaper (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Basic Medicine -- Pharmaceutical Sciences (hsv//eng)
Keyword
- BALB/c
- C3HeB/FeJ
- MmpL3 inhibitor
- modelling
- tuberculosis
- translation
- Farmaceutisk vetenskap
- Pharmaceutical Science
- Farmakokinetik och läkemedelsterapi
- Pharmacokinetics and Drug Therapy
Publication and Content Type
- vet (subject category)
- ovr (subject category)
To the university's database
- By the author/editor
-
Ayoun Alsoud, Ra ...
-
Keutzer, Lina
-
Hölscher, Christ ...
-
Redinger, Natalj ...
-
Hölscher, Alexan ...
-
Schaible, Ulrich
-
show more...
-
Bazaga, Santiago ...
-
Fotouhi, Nader
-
Serbina, Natalya
-
Simonsson, Ulrik ...
-
show less...
- About the subject
-
- MEDICAL AND HEALTH SCIENCES
-
MEDICAL AND HEAL ...
-
and Basic Medicine
-
and Pharmaceutical S ...
- By the university
-
Uppsala University